TMEM106A and hepatocellular carcinoma: 5-Aza-2′-deoxycytidin treatment of hypermethylated TMEM106A in HCCLM3 and MHCC97H cells increased the expression of TMEM106A compared with that in untreated HCC cells (Figure 1B).